Oligo Pool Library Design: Plan Complexity, Coverage, and Controls

A well-planned oligo pool library starts with three decisions: which biological variants or perturbations to test, how many distinct constructs those choices require, and how their representation will be checked during construction and screening. A sequence list defines the intended library; it does not establish that every member will survive amplification, cloning, delivery, and selection.

Before submitting a design, separate biological targets from synthesis sequences, allocate controls explicitly, and identify the experimental steps most likely to limit usable library size. These decisions determine whether the project is ready for synthesis—or whether its scope needs to be reduced.

Start with the experimental readout, then work backward to the sequences needed to produce it.

For a CRISPR screen, the biological target may be a gene, while each library member encodes an individual guide. For a protein variant screen, the target may be an amino acid substitution, while the design file contains the corresponding DNA sequence. For a massively parallel reporter assay, or MPRA, one regulatory sequence may be represented by several independently barcoded constructs.

Record the following before generating the final oligo list:

• Biological objective: the phenotype, activity, or molecular measurement being tested.
• Target set: genes, regulatory elements, variant positions, or explicitly defined sequence combinations.
• Design multiplicity: guides per target, sequence versions per variant, or barcodes per tested element.
• Construct architecture: variable sequence, primer-binding regions, cloning interfaces, and any barcode.
• Assay context: vector, expression system, cell model, delivery method, and selection conditions.
• Readout: direct sequencing of the variable region, barcode counting, or another measurement.

Sequence context can be part of the experiment rather than just packaging. In an MPRA comparison by Klein and colleagues, changing the tested sequence length and surrounding context affected measured regulatory activity. Trimming a sequence solely to fit a synthesis format can therefore change the biological question.

If an intended construct requires assembly from multiple oligos, distinguish the number of synthesis sequences from the number of final constructs. The length of an individual oligo is not the length of the assembled insert.

Designed complexity is the number of distinct members specified in the library. Representation describes which members are present, and at what abundance, at a particular experimental stage.

These quantities should be tracked separately:

Quantity	What it describes	What it does not establish
Biological target count	The genes, elements, or variants under investigation	The number of oligos required
Designed sequence complexity	The distinct synthesis sequences submitted	Successful recovery of every sequence
Cloned library complexity	The distinct intended constructs recovered after cloning	Equal abundance or correct biological activity
Cellular representation	The abundance of library members in the experimental population	Adequate representation after selection
Sequencing representation	The distribution of usable reads assigned to members	Independent molecule counts or functional validation

For example, adding more guides per gene increases sequence complexity without increasing the number of genes tested. Adding barcodes increases construct complexity without necessarily increasing biological diversity.

Published pooled CRISPR workflows treat maintenance of library coverage as an experimental planning problem, with parameters adapted to the screen rather than a single universal coverage requirement. The Joung et al. screening protocol provides this framework from library construction through cellular screening and validation.

Avoid reporting “coverage” without a denominator and a stage. The fraction of designed members detected in a plasmid sample is a different measurement from cells per guide or sequencing reads per barcode.

Review the complete submitted sequence, not only its variable region.

Account for Every Nucleotide

The synthesis-length budget includes all bases present in the ordered oligo:

[ L_{\text{oligo}} = L_{\text{variable region}} + L_{\text{primer regions}} + L_{\text{barcode}} + L_{\text{cloning interfaces}} + L_{\text{other required sequences}} ]

Do not double-count overlapping functional regions. Confirm which sequences are synthesized in the oligo and which are supplied by the vector or added later.

Maintain an annotated architecture alongside the final sequence file. It should show the orientation, boundaries, and purpose of each region, including whether primer-binding sequences or cloning sites remain in the final construct.

Flag Problematic Sequences Without Changing the Experiment

Include checks for:

• Incorrect orientation or reverse-complement handling.
• Unintended internal recognition sites for enzymes used in cloning.
• Duplicate full-length sequences.
• Long homopolymers, repetitive regions, or extreme base composition.
• Potential interactions between primer-binding regions and variable sequences.
• Missing or inconsistent flanking regions.
• Sequence features that prevent unambiguous identification by the planned reads.

Treat these as review flags, not universal rejection rules. A repeat or unusual base composition may be the feature being studied. In that case, preserve the biological sequence and assess whether a different construction or verification strategy is needed.

Likewise, identical sequence rows are not independently identifiable replicates. If separate measurements are required, specify how the resulting constructs will be distinguished.

A barcode is useful when the biological sequence cannot be counted directly or when several distinguishable constructs represent the same tested element. It is not automatically required for every oligo pool library.

Before assigning barcodes, decide:

1. Whether the readout will sequence the variable region or a separate identifier.
2. Whether barcodes are predefined in the synthesis file or introduced during construction.
3. How barcode-to-insert associations will be established and checked.
4. How sequencing errors and ambiguous barcode matches will be handled.
5. Whether the barcode is transcribed or could otherwise influence the assay.

For predefined barcodes, check uniqueness, sequence composition, and compatibility with the decoding method. If error correction is planned, choose barcode separation rules that match that method rather than using an unexplained distance threshold.

For barcodes introduced during cloning, association sequencing is needed before barcode counts can be assigned confidently to biological sequences. A unique barcode is only useful if its corresponding insert is known.

Multiple barcodes can help characterize within-element variation, but they do not replace independent biological replicates. They also should not be assumed to be biologically neutral. Lee and colleagues demonstrated sequence-dependent barcode effects in MPRAs, including effects that depended on assay design and cellular context. Averaging across tags did not fully eliminate these biases.

Controls should be part of the original design, not added after all available capacity has been assigned to experimental sequences.

Control type	Purpose	Design consideration
Negative controls	Estimate background or a baseline response	Choose controls appropriate to the assay; a scrambled sequence is not automatically inactive
Positive controls	Check whether the assay detects an expected response	Use sequences or perturbations supported in the relevant model and conditions
Reference sequences	Provide a comparison for variant effects	Include the relevant wild-type or reference construct
Construction controls	Investigate amplification or cloning problems	Keep their interpretation separate from biological assay controls
Biological replicates	Assess reproducibility across independent experiments	Distinguish them from repeated sequencing or multiple barcodes

For a CRISPR library, distinguish non-targeting guides from guides targeting a presumed neutral locus: they do not necessarily model the same background response. For an MPRA, distinguish an empty-vector baseline from a sequence expected to have low regulatory activity.

The number of controls should follow their intended analytical role. State whether they support normalization, background estimation, assay validation, or comparison across batches. Do not assign a fixed percentage without considering the screen’s size and statistical design.

The following is a simplified planning example, not a Dynegene customer case or a recommended coverage standard.

Assume an MPRA will test:

• 500 regulatory elements.
• Two sequence versions per element: reference and alternative.
• Four predefined barcodes per sequence version.
• 40 additional control sequences, each with four barcodes.
• One complete synthesis oligo per element–barcode combination.

The experimental designs require:

[ 500 \times 2 \times 4 = 4{,}000 ]

The controls require:

[ 40 \times 4 = 160 ]

The preliminary synthesis list therefore contains 4,160 oligo designs, assuming every complete sequence is distinct.

The design file should connect each oligo ID to its element ID, sequence version, barcode, control class, and full synthesis sequence. If two elements produce the same tested sequence, retain the biological annotations but decide whether separate barcoded constructs are needed.

This calculation establishes the design input only. It does not predict synthesis recovery, transformation efficiency, cellular representation, sequencing detection, or statistical power. Four barcodes per sequence is an illustrative assumption, not a validated optimum.

If a complete construct instead requires two synthesis oligos, the synthesis count changes, but the intended number of final barcoded constructs does not automatically double.

Keep the construction workflow tied to decisions about library preservation:

1. Finalize and version the design file. Freeze sequence IDs, annotations, barcode assignments, and exclusion decisions.
2. Amplify the pool using a workflow appropriate to its architecture. Include a plan to assess whether amplification changes abundance distribution.
3. Clone or assemble the intended constructs. Estimate required independent transformants from the construct count and the chosen protocol.
4. Assess the cloned input library. Check identity and abundance before committing to a full screen.
5. Deliver the library into the experimental system. Base representation estimates on the relevant successfully modified population, not simply all cells handled.
6. Collect baseline and endpoint samples. Use them to distinguish pre-existing abundance differences from screen-associated changes.

Transformation, cellular delivery, selection, and sequencing are separate sampling stages. A large number of transformants cannot compensate for a later cellular bottleneck, and deeper sequencing cannot recover members already lost from the experiment.

For lentiviral CRISPR screens, delivery conditions also affect whether cells receive one or multiple perturbations; follow a protocol appropriate to the intended interpretation. The Joung et al. workflow addresses library delivery, coverage planning, and subsequent hit validation.

Design the verification assay alongside the library. Confirm that read length, orientation, and primer placement expose the sequence needed for member identification.

Choose checkpoints that answer specific questions:

• Amplified pool: are expected sequences detectable, and is amplification introducing substantial skew?
• Cloned library: are intended inserts present, and are barcode–insert associations correct where applicable?
• Experimental baseline: what distribution enters the screen?
• Endpoint: how does abundance or activity differ from baseline and controls?

Not every project needs all four checkpoints, but omitting one should be an explicit decision.

Useful QC outputs include:

• Fraction of intended members detected, with the detection threshold stated.
• Read-count distribution, including low-abundance members.
• Missing or ambiguously assigned members.
• Sequence correctness across the region actually covered by reads.
• Barcode–insert association quality, when relevant.
• Agreement between replicates.

A short barcode read does not verify an entire insert. Similarly, absence from a shallow sequencing run is not conclusive evidence that a sequence is physically absent.

For read-budget planning, distinguish raw reads from usable, correctly assigned reads. Average reads per member can support budgeting, but it hides uneven abundance and PCR duplication. Set acceptance criteria in advance and examine the low-abundance tail, not only the mean.

Before requesting synthesis, assemble:

• A versioned sequence file with unique IDs and complete sequences.
• Counts of biological targets, final constructs, and distinct synthesis oligos.
• An annotated architecture with total length and region boundaries.
• Barcode assignments and the association-verification plan.
• Positive, negative, and reference controls with their intended roles.
• Flagged repeats, unusual sequence composition, and other design constraints.
• The intended amplification, assembly, cloning, and readout methods.
• Planned QC checkpoints and project-specific acceptance criteria.
• Requested deliverables and clarification of which construction or QC steps your laboratory will perform.

Consult the published oligo pool synthesis specifications for product-format and ordering information, and confirm compatibility with the complete submitted sequences. Synthesis specifications should not be interpreted as a guarantee of downstream library representation or screening performance.

A design is ready to submit when its sequence count is traceable, its architecture is compatible with the experiment, its controls have defined roles, and its representation checks are planned. With that package prepared, explore Dynegene custom oligo pool services to discuss synthesis requirements for the proposed library.